Related Experiment Video

Updated: May 10, 2026

Evaluation of Caspase Activation to Assess Innate Immune Cell Death
10:23

Evaluation of Caspase Activation to Assess Innate Immune Cell Death

Published on: January 20, 2023

Simvastatin induces caspase-dependent apoptosis and activates P53 in OCM-1 cells

Ying Wang1, Shao-Lin Xu, Ya-Zhen Wu

  • 1Department of Ophthalmology, Second Hospital of JiLin University, ChangChun 130041, China. wangying9201@163.com

Experimental Eye Research
|June 4, 2013
PubMed

Insights

Simvastatin effectively inhibits choroidal melanoma cell (OCM-1) proliferation and induces apoptosis. This cholesterol-lowering drug shows anti-cancer potential by arresting cell cycles and promoting programmed cell death.

Area of Science:

  • Oncology
  • Pharmacology
  • Cell Biology

Background:

  • Simvastatin, a cholesterol-lowering drug, possesses known pleiotropic effects, including anti-cancer activity.
  • The anti-cancer effects of simvastatin specifically in choroidal melanoma are not well understood.

Purpose of the Study:

  • To investigate the effects of simvastatin on the growth, apoptosis, and cell cycle of OCM-1 cells, a model for choroidal melanoma.
  • To elucidate the molecular mechanisms underlying simvastatin's action on these cells.

Main Methods:

  • OCM-1 cells were treated with varying concentrations and durations of simvastatin.
  • Cell viability, proliferation markers (cyclin D1, E, CDK2, P21), reactive oxygen species (ROS) levels, and apoptosis markers (caspase-9, cleaved-caspase-3, P53, Bax, Bcl2, iASPP) were assessed.

Main Results:

  • Simvastatin inhibited OCM-1 cell viability in a dose- and time-dependent manner.
  • Simvastatin induced G1 phase arrest, decreased proliferation markers, and increased the CDK inhibitor P21.
  • Simvastatin increased ROS levels and triggered apoptosis, evidenced by chromatin condensation and altered expression of key apoptosis-related proteins.

Conclusions:

  • Simvastatin demonstrates significant anti-proliferative and pro-apoptotic effects on OCM-1 cells.
  • These findings suggest simvastatin has potential as a therapeutic agent for choroidal melanoma.
Keywords:
OCM-1 cellsapoptosiscaspase-dependent pathwaycell cycle arrestsimvastatin

More Related Videos

Use of a Caspase Multiplexing Assay to Determine Apoptosis in a Hypothalamic Cell Model08:27

Use of a Caspase Multiplexing Assay to Determine Apoptosis in a Hypothalamic Cell Model

Published on: April 16, 2014

Related Concept Videos

Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...